ProPhase Labs, a diagnostics, genomic and biotech-centered company, has entered an asset purchase agreement to acquire exclusive rights to a esophageal pre-cancer screening tool made by Stella Diagnostics, another diagnostics company.
ProPhase Labs to acquire esophageal cancer screening tool
